Cerberus $100 Million Commitment: Cerberus is anchoring Frontier Power USA with a $100 million equity commitment to accelerate project deployments and is extending its existing Eos lockup through year ...
Eos Energy Enterprises (NASDAQ:EOSE) reported a sharp year-over-year increase in first-quarter revenue and outlined a new ...
Eos Energy Enterprises Inc (EOSE) reports a fivefold revenue increase and strategic growth initiatives, while navigating material cost pressures and aiming for positive margins by year-end.
Eos Energy Enterprises (EOSE) up 36.7% pre-market Wednesday after unveiling a partnership with Cerberus Capital Management to deploy long-duration energy storage systems and reporting Q1 profit that ...
Eos Energy Enterprises Reports First Quarter 2026 Financial Results and Announces Frontier Power USA
Announced with Cerberus the formation of Frontier Power USA, a stand-alone purpose-built entity to develop, finance, and operate LDES projects to ...
Canon Inc. ( and Canon Europe Ltd. announced today that Canon will roll out its Authenticity Imaging System for supported ...
Umovity, the joint brand uniting Econolite and PTV Group - together with Tatweer, a leading provider of professional ...
Eos Energy Enterprises, Inc. ( EOSE) Q1 2026 Earnings Call May 13, 2026 8:30 AM EDT Good morning, and welcome to Eos Energy Enterprises' First Quarter 2026 Conference Call. As a reminder, today's call ...
Canon's new camera is well-capable of being a part of its Cinema lineup, but is positioning it as a video-only camera to make ...
Wages have had a bounce back, up 0.8% month on month after three months of negative or stagnant growth. However, with wages up just 0.4% year on year, the data shows a continued trend of being a ...
Eos Energy Enterprises, Inc. (EOSE) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of a loss of $0.28 per share. This compares to a loss of $0.2 per share ...
Autoimmunity BioSolutions (ABS), a biotechnology company developing a personalized, genetically-guided immuno-corrective therapy designed to normalize elevated levels of soluble IL7 receptor (sIL7R), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results